Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Snow

Showing results (571-580 of 596) with videos related to

Pageof 60
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation studyDavid R Colnot, Gert J Ossenkoppele, Jan C Roos, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 geneMaarten P Tabor, Viola M M van Houten, J Alain Kummer, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 17, 1999
Differences in immune status between well-nourished and malnourished head and neck cancer patientsM A van Bokhorst-De van der Schuer, B M von Blomberg-van der Flier, R K Riezebos, et al.
British Journal of Cancer|January 1, 1997
Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell linesB J Braakhuis, I Klaassen, B M van der Leede, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2R de Bree, J C Roos, J J Quak, et al.
Clinical Otolaryngology and Allied Sciences|October 1, 1992
T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general resultsC H Terhaard, G J Hordijk, P van den Broek, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2003
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neckDavid R Colnot, Jan C Roos, Remco de Bree, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 31, 2025
Psychiatric Symptoms Among Adolescents and Young Adults With or Without the Huntingtin Gene ExpansionKelly H Watson, Abagail E Ciriegio, Anna C Pfalzer, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 9, 2000
Survival of malnourished head and neck cancer patients can be predicted by human leukocyte antigen-DR expression and interleukin-6/tumor necrosis factor-alpha response of the monocytevan Bokhorst-de van der Schuer, B M von Blomberg-van der Flier, D J Kuik, et al.
International Journal of Cancer|June 19, 2001
Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomasV M van Houten, P J Snijders, M W van den Brekel, et al.
Pageof 60

Showing results (571-580 of 596) with videos related to

Sort By:
Pageof 60
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation studyDavid R Colnot, Gert J Ossenkoppele, Jan C Roos, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 geneMaarten P Tabor, Viola M M van Houten, J Alain Kummer, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 17, 1999
Differences in immune status between well-nourished and malnourished head and neck cancer patientsM A van Bokhorst-De van der Schuer, B M von Blomberg-van der Flier, R K Riezebos, et al.
British Journal of Cancer|January 1, 1997
Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell linesB J Braakhuis, I Klaassen, B M van der Leede, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2R de Bree, J C Roos, J J Quak, et al.
Clinical Otolaryngology and Allied Sciences|October 1, 1992
T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general resultsC H Terhaard, G J Hordijk, P van den Broek, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2003
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neckDavid R Colnot, Jan C Roos, Remco de Bree, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 31, 2025
Psychiatric Symptoms Among Adolescents and Young Adults With or Without the Huntingtin Gene ExpansionKelly H Watson, Abagail E Ciriegio, Anna C Pfalzer, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 9, 2000
Survival of malnourished head and neck cancer patients can be predicted by human leukocyte antigen-DR expression and interleukin-6/tumor necrosis factor-alpha response of the monocytevan Bokhorst-de van der Schuer, B M von Blomberg-van der Flier, D J Kuik, et al.
International Journal of Cancer|June 19, 2001
Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomasV M van Houten, P J Snijders, M W van den Brekel, et al.
Pageof 60